Skip to content
Wired News Engine – Lifestyle
Author:
Actuate Therapeutics, Inc.
Actuate Therapeutics Announces ASCO Poster Presentations Demonstrating Compelling Clinical and Biomarker Data for Elraglusib in First-Line Metastatic Pancreatic Cancer
June 1, 2026